Financial reports
10-Q
2024 Q2
Quarterly report
31 Jul 24
10-Q
2024 Q1
Quarterly report
8 May 24
10-K
2022 FY
Annual report
19 Mar 24
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
10-Q
2023 Q1
Quarterly report
24 Apr 23
10-K
2022 FY
Annual report
31 Mar 23
10-Q
2022 Q3
Quarterly report
31 Oct 22
10-Q
2022 Q2
Quarterly report
28 Jul 22
10-Q
2022 Q1
Quarterly report
10 May 22
Current reports
8-K
Departure of Directors or Certain Officers
28 Nov 23
8-K
Departure of Directors or Certain Officers
16 Mar 23
8-K
Departure of Directors or Certain Officers
14 Feb 23
8-K
Departure of Directors or Certain Officers
14 Feb 23
8-K
Departure of Directors or Certain Officers
9 Dec 22
8-K
Departure of Directors or Certain Officers
26 Sep 22
8-K
Other Events
17 Mar 22
8-K
Departure of Directors or Certain Officers
7 Oct 21
8-K
Entry into a Material Definitive Agreement
13 Aug 21
8-K
Entry into a Material Definitive Agreement
29 Apr 21
Registration and prospectus
D
$2.27K in options / securities to be acquired, 1 investor
18 Apr 16
D
$1M in equity, sold $1M, 5 investors
23 Oct 15
D
$310.7K in equity / options / securities to be acquired, sold $306.67K, 1 investor
13 Jul 15
D
$86.96K in options / securities to be acquired, 1 investor
7 May 15
S-8 POS
Registration of securities for employees (post-effective amendment)
20 Feb 15
D
$434.81K in options / securities to be acquired, 1 investor
18 Feb 15
D
$5M in debt / options / securities to be acquired, sold $5M, 1 investor
6 Feb 15
S-8
Registration of securities for employees
13 Jan 15
D
Indefinite amount in equity, 39 investors
30 Sep 14
8-A12G
Registration of securities
22 Apr 14
Proxies
DEF 14C
Information statement
22 Jul 19
PRE 14C
Preliminary information
10 May 19
DEFA14A
Additional proxy soliciting materials
28 Sep 18
DEF 14A
Definitive proxy
28 Sep 18
DEF 14A
Definitive proxy
1 May 17
SC 14F1
Statement regarding change in majority of directors
4 Sep 14
DEF 14A
Definitive proxy
23 Jun 14
Other
UPLOAD
Letter from SEC
24 Aug 22
CORRESP
Correspondence with SEC
11 Aug 22
UPLOAD
Letter from SEC
28 Jul 22
CT ORDER
Confidential treatment order
3 Dec 18
CT ORDER
Confidential treatment order
24 Apr 18
CORRESP
Correspondence with SEC
31 Mar 14
EFFECT
Notice of effectiveness
31 Mar 14
UPLOAD
Letter from SEC
20 Mar 14
CORRESP
Correspondence with SEC
10 Mar 14
UPLOAD
Letter from SEC
5 Mar 14
Ownership
3
Kyle Casey
18 Oct 19
SC 13D/A
Twinlab Consolidated Holdings, Inc.
24 Jan 19
3
Carla Goffstein
24 Aug 18
3
Brent Baker
27 Mar 18
3
ALAN S GEVER
24 Mar 17
SC 13D/A
Twinlab Consolidated Holdings, Inc.
20 Mar 17
4
B THOMAS GOLISANO
16 Mar 17
4
MARK BUGGE
9 Mar 17
4
David A Still
9 Mar 17
3
Mary Marbach
12 Dec 16